JP2024506347A5 - - Google Patents
Info
- Publication number
- JP2024506347A5 JP2024506347A5 JP2023548591A JP2023548591A JP2024506347A5 JP 2024506347 A5 JP2024506347 A5 JP 2024506347A5 JP 2023548591 A JP2023548591 A JP 2023548591A JP 2023548591 A JP2023548591 A JP 2023548591A JP 2024506347 A5 JP2024506347 A5 JP 2024506347A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149947P | 2021-02-16 | 2021-02-16 | |
| US63/149,947 | 2021-02-16 | ||
| PCT/US2022/016254 WO2022177835A1 (en) | 2021-02-16 | 2022-02-14 | Treatment of breast cancer using combination therapies comprising gdc-9545 and ipatasertib |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506347A JP2024506347A (ja) | 2024-02-13 |
| JPWO2022177835A5 JPWO2022177835A5 (https=) | 2025-02-18 |
| JP2024506347A5 true JP2024506347A5 (https=) | 2025-02-18 |
Family
ID=80682672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548591A Pending JP2024506347A (ja) | 2021-02-16 | 2022-02-14 | Ｇｄｃ－９５４５およびイパタセルチブを含む併用療法を使用する乳がんの処置 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230381156A1 (https=) |
| EP (1) | EP4294393A1 (https=) |
| JP (1) | JP2024506347A (https=) |
| CN (1) | CN116847839A (https=) |
| TW (1) | TWI881203B (https=) |
| WO (1) | WO2022177835A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115872996B (zh) * | 2023-02-21 | 2023-05-05 | 山东绿叶制药有限公司 | 一种雌激素受体降解剂化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170362228A1 (en) * | 2016-06-16 | 2017-12-21 | Genentech, Inc. | TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF |
| LT3810283T (lt) * | 2018-06-21 | 2023-08-25 | F. Hoffmann-La Roche Ag | 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti |
| CA3109090A1 (en) | 2018-08-17 | 2020-02-20 | F. Hoffmann-La Roche Ag | Diagnostic and therapeutic methods for the treatment of breast cancer |
| CN113194941A (zh) * | 2018-12-19 | 2021-07-30 | 基因泰克公司 | 使用包括akt抑制剂、紫杉烷和pd-l1抑制剂的组合疗法治疗乳腺癌 |
-
2022
- 2022-02-14 JP JP2023548591A patent/JP2024506347A/ja active Pending
- 2022-02-14 TW TW111105229A patent/TWI881203B/zh active
- 2022-02-14 EP EP22708657.6A patent/EP4294393A1/en active Pending
- 2022-02-14 CN CN202280012941.XA patent/CN116847839A/zh active Pending
- 2022-02-14 WO PCT/US2022/016254 patent/WO2022177835A1/en not_active Ceased
-
2023
- 2023-08-15 US US18/449,807 patent/US20230381156A1/en active Pending